Grant Details
Grant Number: |
5R01CA071358-03 Interpret this number |
Primary Investigator: |
Swan, Gary |
Organization: |
Sri International |
Project Title: |
Treatment of Nicotine Dependence in an Hmo Setting |
Fiscal Year: |
1999 |
Abstract
DESCRIPTION: Nicotine replacement therapy for smoking cessation has become
a popular mode of treatment with the advent of nicotine gum and, more
recently, transdermal nicotine (patch). Largely because of ease of
compliance and an improved adverse-effect profile, transdermal nicotine has
become the preferred method for pharmacological therapy. Whereas numerous
clinical trials have demonstrated the efficacy of the patch relative to a
placebo, the level of intensity of adjuvant counseling to achieve an
acceptable rate of cessation remains uncertain. The investigators propose a
study involving 1,900 smokers to be recruited to a randomized five-group
design involving different combinations of transdermal nicotine plus usual
care, telephone based counseling, or group-based counseling. Study
participants will be followed for 13 months to determine a treatment
outcome. Because treatment efficiency cannot be completely addressed
without consideration of patient-treatment interactions and adequate
valuations of the different treatment alternatives, the investigators also
propose to use analytic methods from clinical medicine and pharmacoeconomics
(cost-effectiveness analysis) to focus on these aspects of the overall
research question. This study will be conducted in collaboration with the
nation's largest health maintenance organization, Kaiser Permanente Medical
Care Plan (KPMCP) of Northern California.
Publications
Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
Authors: Bergen A.W.
, Michel M.
, Nishita D.
, Krasnow R.
, Javitz H.S.
, Conneely K.N.
, Lessov-Schlaggar C.N.
, Hops H.
, Zhu A.Z.
, Baurley J.W.
, et al.
.
Source: Plos One, 2015; 10(7), p. e0126113.
EPub date: 2015-07-01 00:00:00.0.
PMID: 26132489
Related Citations
Organic cation transporter variation and response to smoking cessation therapies.
Authors: Bergen A.W.
, Javitz H.S.
, Krasnow R.
, Michel M.
, Nishita D.
, Conti D.V.
, Edlund C.K.
, Kwok P.Y.
, McClure J.B.
, Kim R.B.
, et al.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2014 Dec; 16(12), p. 1638-46.
PMID: 25143296
Related Citations
Pharmacogenetic Smoking Cessation Intervention In A Health Care Setting: A Pilot Feasibility Study
Authors: McClure J.B.
, Swan G.E.
, St John J.
, Fauver R.
, Javitz H.S.
, Bergen A.W.
, Nishita D.
, Niaura R.
, Munafò M.R.
, David S.P.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2013 Feb; 15(2), p. 518-26.
PMID: 22949583
Related Citations
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Authors: Bergen A.W.
, Javitz H.S.
, Krasnow R.
, Nishita D.
, Michel M.
, Conti D.V.
, Liu J.
, Lee W.
, Edlund C.K.
, Hall S.
, et al.
.
Source: Pharmacogenetics And Genomics, 2013 Feb; 23(2), p. 94-103.
PMID: 23249876
Related Citations
Varenicline For Smoking Cessation: Nausea Severity And Variation In Nicotinic Receptor Genes
Authors: Swan G.E.
, Javitz H.S.
, Jack L.M.
, Wessel J.
, Michel M.
, Hinds D.A.
, Stokowksi R.P.
, McClure J.B.
, Catz S.L.
, Richards J.
, et al.
.
Source: The Pharmacogenomics Journal, 2012 Aug; 12(4), p. 349-58.
PMID: 21606948
Related Citations
Utilization Of Services In A Randomized Trial Testing Phone- And Web-based Interventions For Smoking Cessation
Authors: Zbikowski,S.M.
, Jack,L.M.
, McClure,J.B.
, Deprey,M.
, Javitz,H.S.
, McAfee,T.A.
, Catz,S.L.
, Richards,J.
, Bush,T.
, Swan,G.E.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2011 May; 13(5), p. 319-27.
PMID: 21330267
Related Citations
Adherence To Varenicline In The Compass Smoking Cessation Intervention Trial
Authors: Catz,S.L.
, Jack,L.M.
, McClure,J.B.
, Javitz,H.S.
, Deprey,M.
, Zbikowski,S.M.
, McAfee,T.
, Richards,J.
, Swan,G.E.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2011 May; 13(5), p. 361-8.
PMID: 21350041
Related Citations
Cost-effectiveness Of Varenicline And Three Different Behavioral Treatment Formats For Smoking Cessation
Authors: Javitz H.S.
, Zbikowski S.M.
, Deprey M.
, McAfee T.A.
, McClure J.B.
, Richards J.
, Catz S.L.
, Jack L.M.
, Swan G.E.
.
Source: Translational Behavioral Medicine, 2011-03-01 00:00:00.0; 1(1), p. 182-190.
PMID: 21731592
Related Citations
Resequencing Of Nicotinic Acetylcholine Receptor Genes And Association Of Common And Rare Variants With The Fagerström Test For Nicotine Dependence
Authors: Wessel J.
, McDonald S.M.
, Hinds D.A.
, Stokowski R.P.
, Javitz H.S.
, Kennemer M.
, Krasnow R.
, Dirks W.
, Hardin J.
, Pitts S.J.
, et al.
.
Source: Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology, 2010 Nov; 35(12), p. 2392-402.
PMID: 20736995
Related Citations
Smoking Outcome By Psychiatric History After Behavioral And Varenicline Treatment
Authors: McClure,J.B.
, Swan,G.E.
, Catz,S.L.
, Jack,L.
, Javitz,H.
, McAfee,T.
, Deprey,M.
, Richards,J.
, Zbikowski,S.M.
.
Source: Journal Of Substance Abuse Treatment, 2010 Jun; 38(4), p. 394-402.
PMID: 20363092
Related Citations
Behavioral Counseling And Varenicline Treatment For Smoking Cessation
Authors: Swan,G.E.
, McClure,J.B.
, Jack,L.M.
, Zbikowski,S.M.
, Javitz,H.S.
, Catz,S.L.
, Deprey,M.
, Richards,J.
, McAfee,T.A.
.
Source: American Journal Of Preventive Medicine, 2010 May; 38(5), p. 482-90.
PMID: 20409497
Related Citations
Clinical Trial Participant Characteristics And Saliva And Dna Metrics
Authors: Nishita D.M.
, Jack L.M.
, McElroy M.
, McClure J.B.
, Richards J.
, Swan G.E.
, Bergen A.W.
.
Source: Bmc Medical Research Methodology, 2009-10-29 00:00:00.0; 9, p. 71.
PMID: 19874586
Related Citations
Dopamine genes and nicotine dependence in treatment-seeking and community smokers.
Authors: Bergen A.W.
, Conti D.V.
, Van Den Berg D.
, Lee W.
, Liu J.
, Li D.
, Guo N.
, Mi H.
, Thomas P.D.
, Lessov-Schlaggar C.N.
, et al.
.
Source: Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology, 2009 Sep; 34(10), p. 2252-64.
PMID: 19494806
Related Citations
Impact Of Symptoms Experienced By Varenicline Users On Tobacco Treatment In A Real World Setting
Authors: Halperin,A.C.
, McAfee,T.A.
, Jack,L.M.
, Catz,S.L.
, McClure,J.B.
, Deprey,T.M.
, Richards,J.
, Zbikowski,S.M.
, Swan,G.E.
.
Source: Journal Of Substance Abuse Treatment, 2009 Jun; 36(4), p. 428-34.
PMID: 19004600
Related Citations
Mood, Side-effects And Smoking Outcomes Among Persons With And Without Probable Lifetime Depression Taking Varenicline
Authors: McClure,J.B.
, Swan,G.E.
, Jack,L.
, Catz,S.L.
, Zbikowski,S.M.
, McAfee,T.A.
, Deprey,M.
, Richards,J.
, Javitz,H.
.
Source: Journal Of General Internal Medicine, 2009 May; 24(5), p. 563-9.
PMID: 19238488
Related Citations
Canary In A Coal Mine? Interest In Bupropion Sr Use Among Smokers In The Compass Trial
Authors: McClure J.B.
, Jack L.
, Deprey M.
, Catz S.
, McAfee T.
, Zbikowski S.
, Westbrook E.
, Swan G.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2008 Dec; 10(12), p. 1815-6.
PMID: 19023832
Related Citations
Predictors Of 12-month Outcome In Smokers Who Received Bupropion Sustained-release For Smoking Cessation
Authors: Swan G.E.
, Jack L.M.
, Javitz H.S.
, McAfee T.
, McClure J.B.
.
Source: Cns Drugs, 2008; 22(3), p. 239-56.
PMID: 18278978
Related Citations
Joint Effect Of Dopaminergic Genes On Likelihood Of Smoking Following Treatment With Bupropion Sr
Authors: Swan G.E.
, Jack L.M.
, Valdes A.M.
, Ring H.Z.
, Ton C.C.
, Curry S.J.
, McAfee T.
.
Source: Health Psychology : Official Journal Of The Division Of Health Psychology, American Psychological Association, 2007 May; 26(3), p. 361-8.
PMID: 17500623
Related Citations
Financial Burden Of Tobacco Use: An Employer's Perspective
Authors: Javitz H.S.
, Zbikowski S.M.
, Swan G.E.
, Jack L.M.
.
Source: Clinics In Occupational And Environmental Medicine, 2006; 5(1), p. 9-29, vii.
PMID: 16446251
Related Citations
Tailoring Nicotine Replacement Therapy: Rationale And Potential Approaches
Authors: McClure J.B.
, Swan G.E.
.
Source: Cns Drugs, 2006; 20(4), p. 281-91.
PMID: 16599646
Related Citations
Smoking Cessation Treatment: Pharmacogenetic Assessment
Authors: Munafò M.R.
, Lerman C.
, Niaura R.
, Shields A.E.
, Swan G.E.
.
Source: Current Opinion In Molecular Therapeutics, 2005 Jun; 7(3), p. 202-8.
PMID: 15977416
Related Citations
Dopamine Receptor Drd2 Genotype And Smoking Cessation Outcome Following Treatment With Bupropion Sr
Authors: Swan G.E.
, Valdes A.M.
, Ring H.Z.
, Khroyan T.V.
, Jack L.M.
, Ton C.C.
, Curry S.J.
, McAfee T.
.
Source: The Pharmacogenomics Journal, 2005; 5(1), p. 21-9.
PMID: 15492764
Related Citations
Return On Investment Of Different Combinations Of Bupropion Sr Dose And Behavioral Treatment For Smoking Cessation In A Health Care Setting: An Employer's Perspective
Authors: Javitz H.S.
, Swan G.E.
, Zbikowski S.M.
, Curry S.J.
, McAfee T.A.
, Decker D.
, Patterson R.
, Jack L.M.
.
Source: Value In Health : The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 2004 Sep-Oct; 7(5), p. 535-43.
PMID: 15367249
Related Citations
Cost-effectiveness Of Different Combinations Of Bupropion Sr Dose And Behavioral Treatment For Smoking Cessation: A Societal Perspective
Authors: Javitz H.S.
, Swan G.E.
, Zbikowski S.M.
, Curry S.J.
, McAfee T.A.
, Decker D.L.
, Patterson R.
, Jack L.M.
.
Source: The American Journal Of Managed Care, 2004 Mar; 10(3), p. 217-26.
PMID: 15032259
Related Citations
Heterogeneity In 12-month Outcome Among Female And Male Smokers
Authors: Swan G.E.
, Javitz H.S.
, Jack L.M.
, Curry S.J.
, McAfee T.
.
Source: Addiction (abingdon, England), 2004 Feb; 99(2), p. 237-50.
PMID: 14756716
Related Citations
Bupropion Sr And Counseling For Smoking Cessation In Actual Practice: Predictors Of Outcome
Authors: Swan G.E.
, Jack L.M.
, Curry S.
, Chorost M.
, Javitz H.
, McAfee T.
, Dacey S.
.
Source: Nicotine & Tobacco Research : Official Journal Of The Society For Research On Nicotine And Tobacco, 2003 Dec; 5(6), p. 911-21.
PMID: 14668075
Related Citations
Effectiveness Of Bupropion Sustained Release For Smoking Cessation In A Health Care Setting: A Randomized Trial
Authors: Swan G.E.
, McAfee T.
, Curry S.J.
, Jack L.M.
, Javitz H.
, Dacey S.
, Bergman K.
.
Source: Archives Of Internal Medicine, 2003-10-27 00:00:00.0; 163(19), p. 2337-44.
PMID: 14581254
Related Citations
Bupropion Sr And Smoking Cessation In Actual Practice: Methods For Recruitment, Screening, And Exclusion For A Field Trial In A Managed-care Setting
Authors: Jack L.M.
, Swan G.E.
, Thompson E.
, Curry S.J.
, McAfee T.
, Dacey S.
, Bergman K.
.
Source: Preventive Medicine, 2003 May; 36(5), p. 585-93.
PMID: 12689804
Related Citations
A Meta-analysis Of Estimated Genetic And Environmental Effects On Smoking Behavior In Male And Female Adult Twins
Authors: Li M.D.
, Cheng R.
, Ma J.Z.
, Swan G.E.
.
Source: Addiction (abingdon, England), 2003 Jan; 98(1), p. 23-31.
PMID: 12492752
Related Citations